Clinical Trials Update: Jul. 28, 2003
Renal Cell Carcinoma COPD (Chronic Obstructive Pulmonary Disease) Post-Traumatic Stress Disorders
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Renal Cell Carcinoma
A research study to test the efficacy of an investigational medication in patients with advanced renal cell carcinoma (RCC). Volunteers 18 or older with histologically confirmed, advanced (stage IV or recurrent disease) RCC who have not received prior systemic therapy for their disease may be eligible. Research sites located throughout the United States.
COPD (Chronic Obstructive Pulmonary Disease)
A research study evaluating an investigational medication for COPD (chronic obstructive pulmonary disease). Volunteers 35 or older with confirmed diagnosis of COPD who are currently taking medications may be eligible. Research site located in Richmond, Virginia.
Post-Traumatic Stress Disorders
A study to test an FDA-approved medication for epilepsy and the drug's effectiveness in treating post-traumatic stress disorder (PTSD). Volunteers with symptoms of PTSD who are at least 18 years old, in general good health, and not abusing or dependent on alcohol or illicit substances may be eligible. Symptoms may include unwanted memories or flashbacks, trouble sleeping or nightmares, nervousness, irritability or jumpiness or an avoidance of things that are reminiscent of the traumatic, upsetting experience. Research site located in New York, New York.
Copyright 2003 CenterWatch. All rights reserved.